These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28242636)

  • 1. Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main and Multivessel Coronary Artery Disease: Do We Have the Evidence?
    Gersh BJ; Stone GW; Bhatt DL
    Circulation; 2017 Feb; 135(9):819-821. PubMed ID: 28242636
    [No Abstract]   [Full Text] [Related]  

  • 2. Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.
    Sotomi Y; Cavalcante R; van Klaveren D; Ahn JM; Lee CW; de Winter RJ; Wykrzykowska JJ; Onuma Y; Steyerberg EW; Park SJ; Serruys PW
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1564-72. PubMed ID: 27491605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trials.
    Fanari Z; Weiss SA; Zhang W; Sonnad SS; Weintraub WS
    Cardiovasc Revasc Med; 2015 Mar; 16(2):70-7. PubMed ID: 25662779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
    Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivessel disease: percutaneous coronary intervention for classic coronary artery bypass grafting indications.
    Brar SS; Syros G; Dangas G
    Angiology; 2008; 59(2 Suppl):83S-8S. PubMed ID: 18544582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of long-term outcomes after bypass grafting versus drug-eluting stent implantation for left main or multivessel coronary artery disease.
    Chang M; Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Han M; Park SW; Serruys PW; Park SJ
    Catheter Cardiovasc Interv; 2017 Aug; 90(2):177-185. PubMed ID: 28112467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2014 Apr; 7(4):354-61. PubMed ID: 24630886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bypass grafting versus percutaneous intervention in multivessel coronary disease: the current state.
    Sipahi I
    Curr Cardiol Rep; 2015 Feb; 17(2):7. PubMed ID: 25618303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FREEDOM trial: a definitive answer to coronary artery bypass grafting or stents in patients with diabetes and multivessel coronary artery disease.
    Taggart DP
    Eur J Cardiothorac Surg; 2013 Dec; 44(6):978-9. PubMed ID: 24047712
    [No Abstract]   [Full Text] [Related]  

  • 10. Percutaneous Coronary Intervention of Left Main Disease: Pre- and Post-EXCEL (Evaluation of XIENCE Everolimus Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) and NOBLE (Nordic-Baltic-British Left Main Revascularization Study) Era.
    Park DW; Park SJ
    Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28607000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CABG not PCI for most people with complex coronary artery disease.
    BMJ; 2013 Feb; 346():f1289. PubMed ID: 23447349
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple arterial grafting confers survival advantage compared to percutaneous intervention with drug-eluting stents in multivessel coronary artery disease: A propensity score adjusted analysis.
    Raja SG; Benedetto U; Ilsley CD; Amrani M;
    Int J Cardiol; 2015; 189():153-8. PubMed ID: 25897895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of three randomized controlled trials comparing coronary artery bypass grafting with percutaneous coronary intervention using drug-eluting stenting in patients with diabetes.
    Fanari Z; Weiss SA; Zhang W; Sonnad SS; Weintraub WS
    Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):1002-7. PubMed ID: 25185569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of percutaneous coronary intervention in the treatment of left main coronary artery disease.
    Kappetein AP; Head SJ; Osnabrugge RL; van Mieghem NM
    Semin Thorac Cardiovasc Surg; 2014; 26(3):187-91. PubMed ID: 25527012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of three-year outcomes after coronary stenting versus coronary artery bypass grafting in patients with multivessel coronary disease, including involvement of the left anterior descending coronary artery proximally (a subanalysis of the arterial revascularization therapies study trial).
    Aoki J; Ong AT; Arampatzis CA; Vijaykumar M; Rodriguez Granillo GA; Disco CM; Serruys PW
    Am J Cardiol; 2004 Sep; 94(5):627-31. PubMed ID: 15342295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of four randomized controlled trials on long-term outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with stenting for multivessel coronary artery disease.
    Takagi H; Kawai N; Umemoto T
    Am J Cardiol; 2008 May; 101(9):1259-62. PubMed ID: 18435954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial.
    Rezende PC; Hueb W; Garzillo CL; Lima EG; Hueb AC; Ramires JA; Kalil Filho R
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1105-12. PubMed ID: 22944095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CABG Versus PCI: Greater Benefit in Long-Term Outcomes With Multiple Arterial Bypass Grafting.
    Habib RH; Dimitrova KR; Badour SA; Yammine MB; El-Hage-Sleiman AK; Hoffman DM; Geller CM; Schwann TA; Tranbaugh RF
    J Am Coll Cardiol; 2015 Sep; 66(13):1417-27. PubMed ID: 26403338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous coronary intervention or coronary artery bypass surgery for cardiogenic shock and multivessel coronary artery disease?
    Mehta RH; Lopes RD; Ballotta A; Frigiola A; Sketch MH; Bossone E; Bates ER
    Am Heart J; 2010 Jan; 159(1):141-7. PubMed ID: 20102880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left Main Disease: What Is the Correct Approach to Revascularization?
    Rab T; King SB
    Cardiol Rev; 2018; 26(5):219-229. PubMed ID: 29794807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.